Clinical correlates of ambulatory BP monitoring among patients with CKD

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 5, 2013, Pages 721-730

  Iimuro, Satoshi ^a   Imai, Enyu ^b   Watanabe, Tsuyoshi ^c   Nitta, Kosaku ^d   Akizawa, Tadao ^e   Matsuo, Seiichi ^b   Makino, Hirofumi ^f   Ohashi, Yasuo ^g   Hishida, Akira ^h  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e SHOWA UNIVERSITY   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h University of Tokyo   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; NOCTURIA; PERSISTENT PULMONARY HYPERTENSION; PREVALENCE; PROTEINURIA; RISK; SEASONAL VARIATION; SENESCENCE; SLEEP DISORDER; WHITE COAT HYPERTENSION; AGED; AMBULATORY CARE; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; COMORBIDITY; DRUG EFFECTS; JAPAN; KIDNEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SEASON; STATISTICAL MODEL;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY; LINEAR MODELS; MALE; MASKED HYPERTENSION; MIDDLE AGED; MULTIVARIATE ANALYSIS; OFFICE VISITS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEASONS; WHITE COAT HYPERTENSION;

EID: 84877671528     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06470612     Document Type: Article

References (39)

1. Dawber TR, Moore FE, Mann GV: Coronary heart disease in the Framingham study. Am J Public Health Nations Health 47: 4-24, 1957
2. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J: Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 55: 33-50, 1961
3. Kannel WB, Wolf PA, Verter J, McNamara PM: Epidemiologic assessment of the role of blood pressure in stroke. The Framing-ham study. JAMA 214: 301-310, 1970
4. Splansky GL, Corey D, Yang Q, Atwood LD, Cupples LA, Benjamin EJ, D'Agostino RB Sr, Fox CS, Larson MG, Murabito JM, O'Donnell CJ, Vasan RS, Wolf PA, Levy D: The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Fra-mingham Heart Study: Design, recruitment, and initial examination. Am J Epidemiol 165: 1328-1335, 2007
5. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group: Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis. Ann Intern Med 139: 244-252, 2003
6. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42: 1050-1065, 2003
7. Andersen MJ, Khawandi W, Agarwal R: Home blood pressure monitoring in CKD. Am J Kidney Dis 45: 994-1001, 2005
8. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH: Howcommon is white coat hypertension? JAMA 259: 225-228, 1988
9. Pickering TG, Davidson K, Gerin W, Schwartz JE: Masked hypertension. Hypertension 40: 795-796, 2002
10. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y: Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 46: 508-515, 2005
11. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J; Systolic Hypertension in Europe Trial Investigators: Predicting cardiovascular risk using conventional vs ambulatory blood pressurein older patients with systolic hypertension. JAMA 282: 539-546, 1999
12. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K: Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 38: 852-857, 2001
13. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y: Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens 20: 2183-2189, 2002
14. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K: Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cere-brovascular damage in extreme dippers. Hypertension 27: 130- 135, 1996
15. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboli P, Conte G, Gabbai FB, De Nicola L: Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 171: 1090-1098, 2011
16. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T: Silent ce-rebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 16: 692-699, 1990
17. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81: 528-536, 1990
18. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM: Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 7: 23-29, 1994
19. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 24: 793-801, 1994
20. Omboni S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, Mancia G; Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation: Reproducibility and clinical value of nocturnal hypotension: Prospective evidence from the SAMPLE study. J Hypertens 16: 733-738, 1998
21. Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A; CKD-JAC Study Group: Chronic Kidney Disease Japan Cohort (CKD-JAC) study: Design and methods. Hypertens Res 31: 1101-1107, 2008
22. Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A: Chronic Kidney Disease Japan Cohort study:Baseline characteristics and factors associated with causativediseases and renal function. Clin Exp Nephrol 14: 558- 570, 2010
23. van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, Jennum P, Johnson T, Lose G, Mattiasson A, Robertson G, Weiss J; Standardisation Sub-committee of the International Continence Society: The standardisation of terminology in noc-turia: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21: 179-183, 2002
24. JCS Joint Working Group: Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): - Digest version -. Circ J 76: 508-519, 2012
25. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H; Japanese Society of Hypertension Committee: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 32: 3-107, 2009
26. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009
27. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G: Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5: 93-98, 1987
28. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM: Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 291: 1342-1349, 2004
29. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R: Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47: 846-853, 2006
30. Bangash F, Agarwal R: Masked hypertension and white-coat hypertension in chronic kidney disease: A meta-analysis. Clin J Am Soc Nephrol 4: 656-664, 2009
31. Kanno A, Metoki H, Kikuya M, Terawaki H, Hara A, Hashimoto T, Asayama K, Inoue R, Shishido Y, Nakayama M, Totsune K, Ohkubo T, Imai Y: Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: The Ohasama study. Hypertens Res 33: 1192-1198, 2010
32. Kario K, Pickering TG: White-coat hypertension or white-coat hypertension syndrome: Which is accompanied by target organ damage? Arch Intern Med 160: 3497-3498, 2000
33. Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Tsuji I, Imai Y: White-coat hypertension as a risk factor for the development of home hypertension: The Ohasama study. Arch Intern Med 165: 1541-1546, 2005
34. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG: Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 38: 238-245, 2001
35. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C, Hu B, Greene T, Appel L, Phillips RA; African American Study of Kidney Disease and Hypertension Collaborative Research Group: Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 53: 20-27, 2009
36. Hänninen MR, Niiranen TJ, Puukka PJ, Johansson J, Jula AM: Prognostic significance of masked and white-coat hypertension in the general population: The Finn-Home Study. J Hypertens 30: 705-12, 2012
37. Shimbo D, Newman JD, Schwartz JE: Masked hypertension and prehypertension: Diagnostic overlap and interrelationships with left ventricular mass: The Masked Hypertension Study. Am J Hypertens 25: 664-671, 2012
38. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB: Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 131: 564-572, 1999
39. Kario K, Schwartz JE, Pickering TG: Ambulatory physical activity as a determinant of diurnal blood pressure variation. Hypertension 34: 685-691, 1999